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The basophil leucocytes were first observed
in the blood of a patient with myeloid leu-
kaemia by Ehrlich in 1891 (1) and because of
their resemblance to tissue mast cells which
he had previously described and differentiated
from the plasma cells of Waldeyer (2), he
called these "blood mast cells". Considerable
controversy arose over the relationship between
those two types of cells. Ehrlich's conviction
that the "blood mast cell" was of inyeloid
origin and that the tissue mast cell arose in the
mesenchyme from uidifferentiate precursors
has been amply substantiated by later workers.
It is, however, of considerable interest that in
various species there is a reciprocal relationship
in numbers between these cells. Among main-
mals, "blood mast cells" are more numerous in
the rabbit, whereas in rats and mice tissue
mast cells preponderate (3). Apart from its
motility the chief morphological features which
distinguish the basophil leucocyte from the
mast cell are its smaller size, more rounded
shape, its relatively scanty cytoplasm and its
polyrnorphous, usually bibbed, nucleus (4).
There is, however, a danger of drawing too
close an analogy between the two types of
cells. For example, it is well imown that ex-
posure both in vitro and in vivo of rat mast
cells to Compound 48/80 causes them to de-
granulate and to release histamine (5, 6, 7).
It has been claimed that basophil leucocytes
are also degranulated by Compound 48/80
(8, 9) but Levi and Meneghini (10) were un-
able to confirm this. In a recent study, Haye
and Schneider (11) have confirmed that Com-
pound 48/80 will release histamine from rat
mast cells but will not release histamine from
human and rabbit basophils.
This is the second in a series of Special Review
Articles. The Editor is deeply grateful to the au-
thors for their fine contribution to the journal.
* From the Medical Research Council, Unit for
Research on the Experimental Pathology of the
Skin, Medical School, University, Birmingham 15,
England.
There is ample evidence based on studies
carried out on humans, horses and guinea pigs,
to shown that the metachromasia of the gran-
ules of the basophil leucocytes (13, 14, 15) like
that of tissue mast cells (12) is due to the
presence of sulphated mucopolysaccharides—
and heparin in particular. The function of
these mucopolysaccharides is not entirely
understood. It is usually accepted that one of
their functions may be to bind and inacti-
vate histamine within the cell but there seems
to reason why, after release, heparin should
not exercise further intrinsic pharmacological
effects which include an antimitotic activity
(16, 17), the precipitation of collagen from
procollagen (18), inhibition of hyaluronidase
(19, 20), an antiprothrombin activity asso-
ciated with the prevention of agglutination of
platelets (21), the stimulation of hair growth
in rabbits (22), the production of hair loss in
man (23, 24, 25) and a clearing factor in
hyperlipaemia (26, 27). However, in the dis-
cussion at a symposium on mast cells and
basophils Lagunoff (28) suggested that "heparin
is not a physiologically or pharmacologically
reactive agent but rather a structural com-
ponent of the granule that holds the granule
together and serves to bind the two more active
agents, the histamhe and the protease." Both
Coupland (29) and Higginbotham (30) believe
that the polysaccharide is available for binding
purposes and that the structure of the granule
resembles an ion exchange resin. The granule
could thus act as a detoxifying agent.
Almost all the histamine in human blood
is present within the leucocytes of the buffy
coat of blood, and is mainly confined to the
granulocytes; a great increase of the histamine
per unit of blood (up to more than 200 times
the upper limits of normal) is found in chronic
grariulocytic leukaemia; less marked elevations
occur in polycythemia vera, but no increase is
found in polymorphonuclear leucocytosis of
non-leukaemic origin. Valentine (31) investi-
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gated the relationship of blood histamine to
the absolute basophil count in human blood.
His observations made in patients with granu-
locytic leukaernia indicated that the histamine
when expressed on the basis of the amount
present in 10 granulocytes gave a positive
correlation with the basophil percentage and a
negative correlation with the percentage of
other rnyeloid elements, i.e. high histamine
values were related to high percentage of baso-
phils, conversely, values of histamine were
highest when the percentage of myeloid cells
was relatively low. On the basis of these find-
ings Valentine claimed that basophil cells were
the principal carriers of histamine in non-leu-
kaemic blood. Later workers have confirmed
that there is a close correlation between the
number of circulating basophil leucocytes and
the histamine content of the blood (32, 33).
The formation of histamine in human
basophil leucocytes was studied by Lindell,
et al. (34) and Hartman, et cii. (35). Blood
samples were incubated with radioactive histi-
dine and the histamine formed from radio-
active histidine was extracted and measured. It
was thus possible to demonstrate that baso-
phil leucocytes were able to form histamine as
well as storing it.
It would seem that the human basophil—
unlike that of the rat—contains no 5-hydroxy-
tryptamine (36, 37).
It has been claimed that basopenia may
occur in infectious diseases, in acute rheuma-
tism, in anaphylactoid purpura and in thyro-
toxicosis (38, 39, 40, 41, 42, 43, 44, 45). Baso-
penia was considered by Mitchel (45) to be a
result of stress in these diseases. Code, Mitchell
and Kennedy (46), Osada (47), Boseila, et cii.
(48) and Camerada, et al. (49) noted that
experimentally, cortisone, ACTH and thyroxin
could cause a decrease of circulating basophil
leucocytes, but with the ACTH and cortisone
the corresponding eosinopenia was much more
pronounced. It has already been mentioned that
basophilia is a common accompaniment of
granulocytic leukaemia (14).
Physiological variations in the number of
basophil leucocytes in man were studied by
R.orsman (50) who noted that food intake,
moderate exercise and mechanical lesions of
the small blood vessels did not influence the
number of circulating basophils. Males and
females had the same numbers of basophils.
The mean basophil count he found to be 45
per mm3 blood with a tendency to be higher in
subjects between 40 and 59 years of age.
There is no doubt that the scantiness of
knowledge of the function of the basophil is in
part due to the lack of a satisfactory method
for their direct enumeration in capillary and
venous blood. Indirect methods, based on a
total white blood cell count and differential
count are slow and aggregation of platelets
obscures the basophils which become entrapped.
In previous direct methods (51, 52) the stain-
ing of the basophils is often diffuse because of
the water solubility of the mucopolysaccharides.
A more recent method appears to offer prom-
ise. This is based on the addition of cetyl-
pyridinium chloride to the toluidine blue solu-
tion. This lyses the red cells, at the same time
rendering the mucopolysaccharides insoluble
(53). Aluminum sulphate is added to mordant
the dye (54). Using 0.02 ml of blood from a
thumb prick in a 1/10 dilution, counts may be
made in a Fuchs-Rosenthal chamber in 5 to 10
mins. As staining is fast, counts may be done
up to a week after taking the sample. Using
this method Cruickshank and Cooper (53) gave
the mean basophil count of humans as 40 per
mm. which is close to the figure given by Rors-
man (50).
Some early observations of Canon (55),
Franca (56) and Amaniera (57) indicated that
the basophil leucocytes had a close association
with human allergic reactions—basophilia was
noted in patients with asthma and after serum
treatment. Also, studies on rabbits and guinea
pigs (58, 59, 60, 61, 62, 63) demonstrated that
following an injection of antigen the number of
hasophil leucocytes increased in the blood, bone
marrow and at the site where antigen was in-
jected.
Because of the reports of a decrease in the
level of blood histamine in patients with urti-
caria (64, 65) and because of the known high
histamine content of the basophil leucocyte,
Rorsman and others (33, 66, 67, 68) investi-
gated the role of this cell in the circulating
blood of patients with urticaria of different
types. They demonstrated a decrease in the
number of circulating basophils (below 10 cells!
mm) in patients with acute allergic urticaria.
This basopenia was correlated with a decrease
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in the patients blood histamine. No evidence
of such changes was found in the circulating
blood of patients with non-allergic urticaria
(69, 70).
In parallel with the tissue mast cell, Rorsman
(69) considered it likely that the histamine re-
lease and basopenia in urticaria was brought
about by a degranulation mechanism. The bone
marrow of patients with urticaria gave normal
basophil counts. He failed to find any partially
degranulated basophils in the circulation and
pointed out that total degranulation would
render these cells unrecognisable.
Shelley and Juhlin (71), Shelley (72) and
Shelley & Juhlin (73) claimed that basophil
leucocytes from allergic subjects degranulated
when exposed to specific antigen in. vitro and
also that serum from allergic subjects when
mixed with antigen and normal rabbit basophils
caused these to degranulate. On this basis
'direct' and 'indirect' tests were proposed as
diagnostic procedures for several allergic con-
ditions such as drug allergy, insect bites, serum
sickness, contact dermatitis, asthma, hayfever
and ulcerative colitis.
A study has been recently completed on the
direct allergic degranulation of basophils in 52
patients and 43 normal subjects (74). It was
shown that of 21 atopic subjects (sensitive to
various pollens), 13 gave positive direct degran-
ulation of basophils in vitro. Nine of 11 pa-
tients sensitive to penicillin reacted similarly.
It was of interest that in the former group
there was direct correlation between the size
of the prick test reaction and the severity of
the degranulation. However, only two of the
penicillin sensitive patients gave positive skin
tests and thus the basophil test seemed to be
a more reliable index. In all only threequarters
of the subjects with Type I (75) sensitivity
gave positive direct tests.
None of 9 patielits with allergic contact
dermatitis, or of 43 normal subjects gave
positive tests. The basophils of 11 patients
with chronic non-allergic urticaria were also
examined and did not degranulate when ex-
posed to a wide range of common allergens.
These negative findings in relation to contact
sensitivity are consistent with current views
that contact sensitivity is a form of 'delayed'
type hypersensitivity in which antibody is
bound to the cells of the reticulo-lymphoid-
monocyte system (76). Moreover, there is evi-
dence that the specificity of the carrier protein
in haptene protein complexes is important
(77). The role of the basophil in delayed type
hypersensitivity cannot, however, be dismissed
entirely since accumulatioii of these cells at skin
test .sites seems adequately documented, Marked
local basophilia has been described in allergic
contact dermatitis, as well as, in the delayed
reaction following intradermal injection of metal
in sensitive subjects (78, 79, 80). Likewise,
accumulation of the basophils at the site is a
feature of intracutaneous tuberculin test (81,
82). The migration of the basophil leucocytes
to a positive skin test site (which was recorded
in patients with active tuberculosis only) has
been studied at intervals with "Roebuck's skin
window" technique (82). Local basophilia ii
light induced inflamnrnations, and in photo-
allergic contact reactions to 4-chloro-2-hydroxy-
benzoic acid-N-n-butylamide have been reported
also (83, 84, 85). The part the basophils play in
such reactions is not known.
In the indirect system, Haye, et at. (74)
encountered difficulties because of the "toxicity"
of many normal and allergic sera to rabbit
basophils. Only 19 of 29 sera from allergic sub-
jects caused less than 30% degranulation of
rabbit basophils even in the absence of antigen.
These sera were obtained from 12 pollen sen-
sitive subjects and 7 sensitive to penicillin.
Indirect degranulation was obtained from 7
of the atopics and 6 penicillin sensitive patients.
It is, therefore, clear that some two-thirds of
those patients with a type I ('immediate')
hypersensitivity carry a serum factor which is
probably an antibody and which can degranu-
late basophils in the presence of the appropriate
antigen. These conclusions are in close agree-
ment with similar studies (86, 87, 88) and im-
ply that from the clinical viewpoint the re-
sponse of basophil leucocytes 'in vitro' must
be interpreted with caution. It is reasonable
to assume the presence of hypersensitivity when
a positive result occurs, but foolhardy to as-
sume that a negative result indicates the ab-
sence of hypersensitivity.
The actual mechanism of degranulation
and histamine release, however, is well worthy
of closer study and the evidence suggests that
they are not necessarily coincidental. For exam-
ple, in the study just described, measurements
were made of histamine before and after ex-
posure of five allergic subjects' basophils to
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antigen at 37°C using heparin as anticoagulant.
Although antigen caused histamine release in
all 5, degranulation occurred in. only two. More-
over, it was shown that in the human at least
degranulation could be obtained at 20°C and
also in the presence of EDTA although it is
well substantiated that histamine release only
occurs at 37°C and requires the presence of
Ca (89, 90). A further logical difficulty has
already been raised (69)—if a basophil has
degranulated, how does one recognise it?
Attempts have been made to clarify some
of these problems by experiments on rabbits
and guinea pigs (91). Basophil counts were
made on the same preparations which were
used for degranulation tests and experiments
were made at 37C and 20°C as well as in the
presence of EDTA and heparin. Both species
behaved similarly—a dramatic fall in the baso-
phil count occurred only in the heparin prep-
aration at 37°C. However, degranulation could
be detected in all preparations—maximal in
the heparin preparation at 37°C, and minimal
in the EDTA preparation at 20CC. Thus the
effect of antigen would seem to be a total dis-
ruption of a proportion of the basophils asso-
ciated with partial degranulation of others.
This implies that the granules still retain some
physical contact with the cytoplasm of the cell.
In conclusion, it would seem that although
we now know how basophils behave under a
variety of circumstances, we are not much wiser
as to actual functions performed in various
physiological and pathological conditions. Be-
cause it is so much easier to deal with the mast
cell, it has been the subject of more intensive
investigation and there has been a tendency to
translate basophil function in terms of mast cell
behavior during the whole of this century. A
new look at basophils in their own right is
suggested.
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